Joanne Mankor

4PUBLICATIONS
37CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Feb 01, 2024
Combining Genomic Biomarkers to Guide Immunotherapy in Non-Small Cell Lung Cancer.

Joris van de Haar, Joanne M Mankor, Karlijn Hummelink

|Jan 09, 2024
Exploring the Cost Effectiveness of a Whole-Genome Sequencing-Based Biomarker for Treatment Selection in Patients with Advanced Lung Cancer Ineligible for Targeted Therapy.

|May 19, 2023
PD-L1 checkpoint blockade promotes regulatory T cell activity that underlies therapy resistance.

Mandy van Gulijk, Anneloes van Krimpen, Sjoerd Schetters

|Aug 18, 2021
Early Cost Effectiveness of Whole-Genome Sequencing as a Clinical Diagnostic Test for Patients with Inoperable Stage IIIB,C/IV Non-squamous Non-small-Cell Lung Cancer.

Martijn J H G Simons, Valesca P Retèl, Bram L T Ramaekers

Pageof 1

Frequent Collaborators

3 joint publications

Joachim G J V Aerts

2 joint publications

Martijn J H G Simons

2 joint publications

Valesca P Retèl

2 joint publications

Bram Ramaekers